Genetic factors influence insulin resistance through various mechanisms, some of which semaglutide addresses directly or indirectly
To view digital features for this article, go to Introduction Obesity is a public health problem in the US, with increasing prevalence over the past 20 years [1]
Purpose-built for physicians Use of GLP-1 agonists prior to THA may increase postoperative nausea, vomiting Key takeaways: Postoperative nausea and vomiting occurred in 18.2% of patients prescribed GLP-1s vs
In type 2 diabetes , the body either becomes resistant to insulin, doesnt produce enough insulin, or both, making blood sugar control difficult
Safety Monitoring: Who Needs Enhanced Lab Surveillance Patients with pre-existing kidney disease, liver cirrhosis, thyroid nodules, or personal/family history of medullary thyroid cancer require more frequent biomarker checks and may not be candidates for GLP-1 therapy